
Please try another search
Read-Gene S.A. engages in the detection, prevention, and treatment of various types of cancer. Its activities include chemoprevention, clinical tests, and genetic tests. The chemoprevention segment engages in the use of natural or synthetic substances to inhibit, reverse, or delay the process of cancer. The company conducts clinical trials in cancer patients; and provides genetic tests and genetic oncology consultations to all patients for the most common cancers, such as breast, ovary, prostate, stomach, large intestine, and breast cancer. It also operates an online platform. The company was incorporated in 2005 and is based in Dobra, Poland. Read-Gene S.A. is a subsidiary of Gen-Pat-Med Sp. z o.o.
Name | Age | Since | Title |
---|---|---|---|
Bronislaw Ziemianim | - | - | Independent Chairman of the Supervisory Board |
Tomasz Huzarski | - | - | Independent Chairman of the Supervisory Board |
Jacek Gronwald | - | - | Independent Vice Chairman of the Supervisory Board |
MacKay James | - | - | Member of the Advisory Board |
Gardovskis Janis | - | - | Member of the Advisory Board |
Edward Karol Sikora | 73 | - | Member of the Advisory Board |
Yannoukakos Drakoulis | - | - | Member of the Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review